Another Gold High? Here's the Move Wall Street Is Missing ...
Gold just surged past $4,200, up 45% in a year - but Sean Brodrick says $6,900 could be next. History shows when gold booms, one hidden play has delivered far bigger gains - 21x, 49x, even 1,386x. The same strategy once handed 26,000% profits. And Sean says it's back on the table now.
Tradr Expands Leveraged Lineup With 4 New Single-Stock ETFs Targeting AI Infrastructure Firms
The new ETFs offer 2x exposure to Bloom Energy, Celestica, NANO Nuclear Energy, and Synopsys—each linked to America's expanding AI infrastructure.
Serve Robotics Shares Skid: What's Going On?
Serve Robotics Inc (NASDAQ:SERV) shares are trading lower on Thursday. The company disclosed its financial results for the third quarter.
Buy This Stock Tomorrow? - Ad
A renowned former hedge fund manager - friends to some of the biggest investors in the world - just released a new list of his favorite AI stocks... and not a single Magnificent 7 name made the cut. Instead, an AI stock you've likely never heard of just flagged as "near-perfect" in his new investing scoring system.
California revokes 17,000 driver's licenses. But the state disputes it is over immigration concerns
California plans to revoke 17,000 commercial driver’s licenses given to immigrants after the Trump administration raised concerns about people in the country illegally receiving licenses to drive a semitruck or a bus. But Gov. Gavin Newsom said that isn't the reason.
These are the 37 donors helping pay for Trump's $300 million White House ballroom
WASHINGTON (AP) — President Donald Trump says his $300 million White House ballroom will be paid for “100% by me and some friends of mine.”
After 50 Years of Chemo, One Biotech Could Lead the Next Cancer Breakthrough - Ad
For decades, toxic chemotherapy defined cancer care. This biotech's innovative approach could finally change that. With early results showing precision without poison, this story is one investors will want to see early.
How To Earn $500 A Month From Applied Materials Stock Ahead Of Q4 Earnings
Applied Materials, Inc. is expected to report lower quarterly earnings and revenue on Nov. 13. Analysts recommend buying with a $250 target.
Why a Visa-Mastercard legal settlement could lead to your rewards credit card getting declined
NEW YORK (AP) — Visa and Mastercard have proposed a settlement in their long-running legal dispute with merchants and retailers over how much they charge merchants to accept their cards.
The New Gold Trade Dominating on Wall Street - Ad
Wall Street has been making headlines lately for piling into gold. According to Dr. David Eifrig, the gold bull run is just getting started. He says you should move your money to his No. 1 gold stock immediately (not a miner or ETF but it has 1,000% upside potential.)
Jury awards $28M to family of a United Nations consultant killed in Boeing 737 Max crash in Ethiopia
A federal court jury has awarded more than $28 million to the family of a woman who died in the crash of a Boeing 737 Max jetliner in Ethiopia more than six years ago.
From beaches to ski slopes, photos show how cameras keep watch all over China
BEIJING, China (AP) —
"Tech Prophet" Who Predicted the iPhone Now Predicts... - Ad
George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit before November 18's bombshell.
Microsoft Builds Massive AI 'Super Factory' In Atlanta To Power OpenAI And Elon Musk's xAI
Microsoft Corp (NASDAQ: MSFT) is building an AI super factory in Atlanta to double its data center footprint and keep up with the $400 billion AI industry.
This Undervalued Biotech Might Have Just Proven Its Star Drug's Staying Power
Apellis reports five-year Syfovre data showing up to 31% slower GA lesion growth, reinforcing strong long-term efficacy and analyst optimism.
Speculative? Yes. But This Memecoin Has Serious Fundamentals. - Ad
Most memecoins are driven by hype-but this one might be different. Backed by a real use case and unexpected investor interest, our analysts believe it could emerge as one of the strongest performers in the coming cycle.
A Vermont cycling apparel company is trying to survive Trump's tariffs. Will the Supreme Court help?
BURLINGTON, Vt. (AP) — From the moment President Donald Trump on nearly every country, Nik Holm feared the company he leads might not survive.
Another Gold High? Here's the Move Wall Street Is Missing ... - Ad
Gold just surged past $4,200, up 45% in a year - but Sean Brodrick says $6,900 could be next. History shows when gold booms, one hidden play has delivered far bigger gains - 21x, 49x, even 1,386x. The same strategy once handed 26,000% profits. And Sean says it's back on the table now.
Tesla's First Semi Vehicle Customer After Full Production Launch Is….Tesla?
Tesla Semi is one of several vehicles set for full-scale production in 2026 from Tesla. Here's the company's first major customer.
Meta Stock Continues To Slide: What's Going On?
Meta Platforms Inc (NASDAQ:META) shares are trading lower on Wednesday. Here's everything you need to know.
Why Wall Street Is Piling Into the "Debasement Trade" - Ad
Wall Street has been making headlines lately for piling into a strange new money move. What they've dubbed the "Debasement Trade"... And it could affect you and your money in a MAJOR way. Dr. David Eifrig's latest warning deserves your attention.
Michael Caine and Matthew McConaughey partner with ElevenLabs for AI voice cloning
NEW YORK (AP) — Oscar-winning actors Michael Caine and Matthew McConaughey have made deals with voice-cloning company ElevenLabs that will allow its artificial intelligence technology to replicate their voices.
Best ETF For The Critical Minerals Boom? Here Are Rare Earth Winners
Here's how VanEck's REMX and Amplify's BATT stack up in the fight for dominance over critical minerals and the clean energy supply chain.
The K7 Is Changing the Economics of Security - Ad
$65-an-hour guards can't compete with a $15-an-hour AI machine that never sleeps. The K7 delivers nonstop protection and smarter analytics that improve with every patrol.
FDA says drugmakers have recalled a blood pressure medicine tainted with a cancer-causing chemical
The U.S. Food and Drug Administration says drugmakers have recalled more than a half-million bottles of the blood pressure medication prazosin hydrochloride over concerns it may include a cancer-causing chemical.
Dave Ramsey Reveals Why Millionaires Crush Mortgages Early
Dave Ramsey advises buying a home with cash, citing his firm's survey of millionaires who often retire their mortgages in about 10 years.
America's Next Security Revolution Has Begun - Ad
Built for endurance, powered by AI, and proven in the field, the K7 is redefining protection for ports, energy hubs, and cities across the nation. The rollout is already underway.
Palantir, Kimberly-Clark, Hims & Hers, Navitas And Cipher Mining: Why These 5 Stocks Are On Investors' Radars Today
PLTR, KMB, HIMS, NVTS, CIFR were among the stocks seen trending among investors on Monday, Nov. 3, 2025.
A medley of tech gifts for everyone on your holiday shopping list
NEW YORK (AP) — It's the most wonderful time of the year, unless you want to find the perfect gifts for .
This Overlooked Memecoin Is Showing Early Breakout Signals - Ad
We've been tracking one small memecoin that checks all the boxes: strong on-chain signals, real traction, and an entry point that could offer serious upside. It's not on many radars yet-but that could change fast.
Trump no-show at big Asian economic forum may risk US reputation in region
GYEONGJU, South Korea (AP) — A hot mike caught U.S. President Donald Trump saying that his much-anticipated meeting Thursday , meant to settle the most important trade relationship in the world, would be “three, four hours” and he would then fly back to Washington.
AI In Finance: How Autonomous Agents Are Changing Fintech
Benzinga hosts a panel titled "AI In Finance: How Autonomous Agents are Changing Financial Services" examining the use of AI in fintech.
Buy This Stock Tomorrow? - Ad
A renowned former hedge fund manager - friends to some of the biggest investors in the world - just released a new list of his favorite AI stocks... and not a single Magnificent 7 name made the cut. Instead, an AI stock you've likely never heard of just flagged as "near-perfect" in his new investing scoring system.
Nearly 8 Million Shiba Inu Vanish After First SHIB ETF Filing Shakes Market
Nearly 8 million Shiba Inu (CRYPTO: SHIB) tokens have been incinerated following the inaugural filing of a Shiba Inu ETF, rekindling interest in the popular meme token.
Nvidia Packaging Partner Amkor Logs Momentum Gain— Up Over 30% YTD On AI Surge
Amkor Technologies (AMKR) hits top momentum percentile, up over 30% YTD as Nvidia's key CoWoS/HBM partner. AI surge drives gains.
After 50 Years of Chemo, One Biotech Could Lead the Next Cancer Breakthrough - Ad
For decades, toxic chemotherapy defined cancer care. This biotech's innovative approach could finally change that. With early results showing precision without poison, this story is one investors will want to see early.
Fintech company Fiserv slashes guidance, shuffles leadership after big earnings miss
WASHINGTON (AP) — Fiserv shares careened to their lowest level in more than five years Wednesday after the fintech payment company badly missed Wall Street's profit targets, lowered its forecast and announced a shake-up in leadership.
Tempus AI Stock (TEM) Slides 6% Overnight: Here's Why The Stock Is Trending
Tempus AI shares fell 6.02% in after-hours trading Tuesday following its third-quarter earnings report.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.